Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma
Open Access
- 12 June 2014
- Vol. 120 (20), 3154-3158
- https://doi.org/10.1002/cncr.28844
Abstract
BACKGROUND Uterine leiomyosarcoma (ULMS) is identified in 0.1% to 0.2% of hysterectomy specimens of presumed leiomyoma. To date, there is no preoperative technique that reliably differentiates ULMS from uterine leiomyoma. Increasing use of minimally invasive approaches for the management of leiomyomas may result in inadvertently morcellated ULMS with resultant intraperitoneal dissemination of tumor. The objective of this study was to assess the impact of intraperitoneal morcellation on the outcomes of patients with ULMS. METHODS In this retrospective cohort study, all patients with ULMS who attended the authors' institutions from 2007 to 2012 were reviewed. Demographics and outcomes were compared between those who underwent morcellation or total abdominal hysterectomy (TAH) as their first surgery for uterus-limited ULMS. RESULTS In total, 58 patients were identified, including 39 who underwent TAH and 19 who underwent intraperitoneal morcellation. Intraperitoneal morcellation was associated with a significantly increased risk of abdominal/pelvic recurrences (P = .001) and with significantly shorter median recurrence-free survival (10.8 months vs 39.6 months; P = .002). A multivariate adjusted model demonstrated a >3 times increased risk of recurrence associated with morcellation (hazard ratio, 3.18; 95% confidence interval, 1.5-6.8; P = .003). CONCLUSIONS Intraperitoneal morcellation of presumed leiomyoma worsens the outcomes of women with ULMS. Because there are no reliable preoperative techniques to distinguish ULMS from benign leiomyoma, all efforts to minimize intraperitoneal uterine morcellation should be considered. [See editorial on pages 000-000, this issue.] Cancer 2014;120:3154–3158. © 2014 American Cancer Society.Keywords
This publication has 20 references indexed in Scilit:
- Peritoneal Dissemination Complicating Morcellation of Uterine Mesenchymal NeoplasmsPLOS ONE, 2012
- A nomogram to predict postresection 5‐year overall survival for patients with uterine leiomyosarcomaCancer, 2011
- Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcomaEuropean Journal of Cancer, 2009
- Hysteroscopic Morcellator for Removal of Intrauterine Polyps and Myomas: A Randomized Controlled Pilot Study among Residents in TrainingJournal of Minimally Invasive Gynecology, 2008
- Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign diseaseInternational Journal of Gynecologic Cancer, 2008
- Prognostic factors and survival in 1396 patients with uterine leiomyosarcomasCancer, 2008
- Perioperative complication rate in 1706 patients after a standardized laparoscopic supracervical hysterectomy techniqueJournal of Minimally Invasive Gynecology, 2006
- Uterine fibroidsThe Lancet, 2001
- The Frequency of Uterine LeiomyomasAmerican Journal of Clinical Pathology, 1990
- Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomasAmerican Journal of Obstetrics and Gynecology, 1990